- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£739GBP
- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£739GBP
- Report
- March 2024
- 132 Pages
Global
From €870EUR$950USD£739GBP
- Report
- December 2023
- 11 Pages
Global
From €4577EUR$5,000USD£3,890GBP
- Report
- August 2022
- 9 Pages
Global
From €2884EUR$3,150USD£2,451GBP
- Report
- April 2024
- 212 Pages
Global
From €2288EUR$2,499USD£1,944GBP
€3268EUR$3,570USD£2,777GBP
- Report
- March 2022
- 236 Pages
Global
From €2215EUR$2,419USD£1,882GBP
€3164EUR$3,456USD£2,689GBP
- Report
- January 2022
- 220 Pages
Global
From €2379EUR$2,598USD£2,022GBP
€3398EUR$3,712USD£2,888GBP
- Report
- December 2021
- 251 Pages
Global
From €2379EUR$2,598USD£2,022GBP
€3398EUR$3,712USD£2,888GBP
The Coronary Stent market is a segment of the Cardiovascular Devices industry. Coronary Stents are medical devices used to treat coronary artery disease, a condition caused by the narrowing of the coronary arteries. Stents are inserted into the artery to keep it open and allow for improved blood flow. They are typically made of metal mesh and coated with a drug to prevent the artery from narrowing again. Coronary Stents are used in conjunction with other treatments such as angioplasty and bypass surgery.
The Coronary Stent market is highly competitive, with a number of companies offering a variety of products. Companies in the market include Abbott, Boston Scientific, Medtronic, Biosensors International, and Terumo. Show Less Read more
